SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-24-001591
Filing Date
2024-02-12
Accepted
2024-02-12 16:46:29
Documents
23
Period of Report
2024-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tenx_8k.htm   iXBRL 8-K 32818
2 WARRANT AGENCY AGREEMENT tenx_ex41.htm EX-4.1 97592
3 FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT tenx_ex42.htm EX-4.2 93248
4 FORM OF COMMON STOCK PURCHASE WARRANT tenx_ex43.htm EX-4.3 103262
5 PLACEMENT AGENCY AGREEMENT tenx_ex101.htm EX-10.1 95792
6 FORM OF SECURITIES PURCHASE AGREEMENT tenx_ex102.htm EX-10.2 199978
7 PRESS RELEASE tenx_ex991.htm EX-99.1 13246
13 tenx_ex991img1.jpg GRAPHIC 4928
  Complete submission text file 0001654954-24-001591.txt   942477

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA tenx-20240208.xsd EX-101.SCH 5720
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tenx-20240208_lab.xml EX-101.LAB 14667
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tenx-20240208_cal.xml EX-101.CAL 898
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tenx-20240208_pre.xml EX-101.PRE 9275
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tenx-20240208_def.xml EX-101.DEF 2099
24 EXTRACTED XBRL INSTANCE DOCUMENT tenx_8k_htm.xml XML 3910
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 24620762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)